Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
14.8M
-
Shares change
-
+2.7M
-
Total reported value, excl. options
-
$243M
-
Value change
-
+$49.2M
-
Put/Call ratio
-
0
-
Number of buys
-
44
-
Number of sells
-
-22
-
Price
-
$16.35
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q2 2020
90 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q2 2020.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.8M shares
of 48M outstanding shares and own 30.88% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (4.85M shares), SENTINEL PENSION ADVISORS INC (1.1M shares), AMERIPRISE FINANCIAL INC (838K shares), VANGUARD GROUP INC (782K shares), Park West Asset Management LLC (769K shares), ROYCE & ASSOCIATES LP (680K shares), Russell Investments Group, Ltd. (674K shares), BlackRock Inc. (608K shares), Ranger Investment Management, L.P. (463K shares), and Tarsadia Capital, LLC (438K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.